BD delivers a broad portfolio of products across the hospital continuum in the fight against AMD with the capabilities to prevent the spread of infections; surveillance systems to track, and report AMR outbreaks; and diagnostics to screen, test, and diagnose infections. These accurate and reproducible diagnostics can help identify CDC-and WHO identified antimicrobial- resistant threats and proved confidence in the appropriate antimicrobial agents 1,2,. Equipping laboratory personnel with the right microbiology tools will help improve efficiencies, quality, and time to accurate patient treatment 3-5  

1. Thomason K, Thomas G, Turner G, et al High Stringency Evaluation of BD Phoenix CPO Detect Test for Detection and Classification of Carbapenemase. Presented at: European Congress of Clincal Microbiology and Infectious Disease (ECCMID) Annual Meeting Vienna, Austria April 22025, 2017. Abstract 1075 
2. Centres for Disease Control and Prevention (CDC). Antibiotic Resistance Threats in the United States, 201. Atlanta: CDC; 2013  
3. Junks AD, Arbefeville SS, Howard WJ, Richter SS. Comparison of BD phoenix AP workflow with Vitek 2. J Clin Microbiol. 201; 48:1929-1931 
4. Sellenriek P, Holmes J, Ferret R, et al. Comparison of MicroScan Walk-Away®, Phoenix™ and VITEK-TWO® Microbiology Systems used in the Identification and Susceptibility Testing of Bacteria Presented at 105th American Society for Microbiology; Washington, DC; 2005. Abstract C-203 
5. Perez KK, Olsen RJ, Musick WL, et al. Integrating rapid pathogen identification and antimicrobial stewardship significantly decreases hospital costs. Arch Pathol Lab Med. 2013; 137:1247-1254.